Bill number does not exist. Enter a vaild keyword.
Original
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Opposite
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Review in
Original Chamber
Passed Both
Chambers
Conf. Cmte
(if necessary)
To Governor
Title
Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance
Sponsored by
Delegates Cox, Boteler, Hornberger, McComas, and Thiam
Status
In the House - Hearing 3/03 at 1:30 p.m.
Analysis
Fiscal and Policy Note
Synopsis
Requiring health insurance carriers to limit the amount a covered individual is required to pay in copayments or coinsurance for a covered prescription insulin drug to $30 for a 30-day supply; and requiring the Prescription Drug Affordability Board to conduct a certain cost review of prescription insulin drug products.
Committee Testimony
Details
Bill File Type: Regular
Effective Date(s): June 1, 2022
Legislation History
Chamber
House
Calendar Date
2/11/2022
Legislative Date
2/11/2022
Action
First Reading Health and Government Operations
Proceedings
Chamber
House
Calendar Date
2/14/2022
Legislative Date
2/14/2022
Action
Hearing 3/03 at 1:30 p.m.
Proceedings
Chamber Calendar Date Legislative Date Action Proceedings
House 2/11/2022 2/11/2022 First Reading Health and Government Operations
House 2/14/2022 2/14/2022 Hearing 3/03 at 1:30 p.m.
Text - First - Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance
(   15-822.1, 15-847.1   )
Last Updated: 7/8/2022 2:41 PM
Click to return on the top page